Larimar Therapeutics (LRMR) Payables (2013 - 2025)
Larimar Therapeutics (LRMR) posted Payables of $5.2 million for Q4 2025, down 53.01% on a QoQ basis from $11.1 million in Q3 2025, and up 115.18% year-over-year from $2.4 million in Q4 2024.
Larimar Therapeutics (LRMR) Payables (2013 - 2025) Analysis & Trends
Larimar Therapeutics' Payables history runs 13 years deep, the most recent figure standing at $5.2 million for Q4 2025.
- Quarterly Payables rose 115.18% year-over-year to $5.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.2 million (up 115.18% YoY) and the FY2025 annual result came in at $5.2 million, up 115.18% from the prior year.
- Payables was $5.2 million for Q4 2025 at Larimar Therapeutics, down from $11.1 million in the prior quarter.
- Across five years, Payables topped out at $11.1 million in Q3 2025 and bottomed at $425000.0 in Q2 2022.
- A 5-year average of $2.5 million and a median of $1.8 million in 2021 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables plunged 71.25% — and 2025, when it soared 558.36%.
- Larimar Therapeutics' Payables stood at $1.7 million in 2021, then gained by 1.57% to $1.7 million in 2022, then fell by 23.9% to $1.3 million in 2023, then soared by 88.93% to $2.4 million in 2024, then surged by 115.18% to $5.2 million in 2025.
- Business Quant data shows LRMR's Payables at $5.2 million in Q4 2025, $11.1 million in Q3 2025, and $4.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 80.54 Mn |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | 5.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.22 Mn |
| Sep 30, 2025 | 11.10 Mn |
| Jun 30, 2025 | 4.17 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 756,000.00 |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 695,000.00 |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 849,000.00 |
| Jun 30, 2022 | 425,000.00 |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Jun 30, 2021 | 1.46 Mn |
| Mar 31, 2021 | 3.23 Mn |